Table 1.

Site of sampling, resistance profile, and genotypes (DLST and MLST) of MSSA isolates from 28 patients that were determined to be positive by the GeneXpert MRSA assay

Patient no.	Sitea	Resistance profileb	DLST	STc	CCd
1	Nose	Pen, Cip, Ery	2-2	105	5
2	Nose and inguinal*	Pen, Clin, Cip, Ery, Fu	3-3	8	8
3	Nose	Pen, Gm, Fu	288-3	8	8
4	Nose	Pen, Fu	288-3	828	8
5	Nose	Pen, Fu	288-19	SLV8	8
6	Nose and throat*	Pen, Fu	288-231	8	8
7	Nose	Pen, Fu	492-231	8	8
8	Nose	Pen, Fu	534-122	8	8
9	Nose	Pen	533-353	72	8
10	Nose	No resistance	538-520	10	10
11	Nose and throat*	Pen	5-46	1	15
12	Inguinal	Pen	5-46	1	15
13	Throat	No resistance	503-489	1	15
14	Nose	Pen	5-46	852	15
15	Inguinal	No resistance	496-490	3	15
16	Throat and inguinal*	No resistance	532-228	3	15
17	Nose	Cip	527-72	15	15
18	Throat	Pen	537-152	22	22
19	Nose and throat*	Pen	122-109	34	30
20	Nose	Pen	122-516	34	30
21	Nose	Pen	489-485	45	45
22	Throat	Pen	86-76	59	59
23	Throat	Pen, Ery	86-76	59	59
24	Nose	Pen	86-76	59	59
25	Nose	Cip	536-41	78	88
26	Throat	Pen	217-519	88	88
27	Nose	No resistance	371-184	97	97
28	Nose and throat*	No resistance	162-486	SLV291	398

^aIn six patients, indicated by an asterisk, the same MSSA was found in two samples.

^bAn antibiogram was performed with oxacillin (Ox), ceftriaxone (Cef), penicillin (Pen), gentamicin (Gm), ciprofloxacin (Cip), clindamycin (Clin), erythromycin (Ery), cotrimoxazole (SxT), fucidin (Fu), and rifampin (Rif).

^cSLV, new ST which is a single locus variant of the mentioned ST.

^dCC, clonal complex.